Literature DB >> 10805359

Bacterial vaginosis: the quest continues.

S Faro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10805359      PMCID： PMC1784666          DOI： 10.1002/(SICI)1098-0997(2000)8:2<75::AID-IDOG1>3.0.CO;2-E

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN： 1064-7449


× No keyword cloud information.
  3 in total

1.  A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.

Authors:  Jose A Simoes; Luis G Bahamondes; Rodrigo P S Camargo; Valeria M N Alves; Lourens J D Zaneveld; Donald P Waller; Jill Schwartz; Marianne M Callahan; Christine K Mauck
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

2.  Purification and characterization of enterocin 62-6, a two-peptide bacteriocin produced by a vaginal strain of Enterococcus faecium: Potential significance in bacterial vaginosis.

Authors:  Diane C Dezwaan; Michael J Mequio; Julia S Littell; Jonathan P Allen; Silvia Rossbach; Vivien Pybus
Journal:  Microb Ecol Health Dis       Date:  2007-07-30

3.  Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by Enterococcus faecium 62-6: potential significance for bacterial vaginosis.

Authors:  Maureen C Kelly; Michael J Mequio; Vivien Pybus
Journal:  Infect Dis Obstet Gynecol       Date:  2003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.